GlycoMimetics Analyst Ratings
GlycoMimetics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/15/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 05/04/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 03/30/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 02/16/2023 | 403.14% | HC Wainwright & Co. | $13 → $8 | Maintains | Buy |
| 08/04/2022 | 717.61% | HC Wainwright & Co. | $14 → $13 | Maintains | Buy |
| 11/12/2021 | 151.57% | Jefferies | $3 → $4 | Upgrades | Hold → Buy |
| 12/08/2020 | 843.4% | Roth Capital | $9 → $15 | Maintains | Buy |
| 07/31/2020 | 843.4% | HC Wainwright & Co. | $16 → $15 | Maintains | Buy |
| 03/02/2020 | 906.29% | HC Wainwright & Co. | $18 → $16 | Reiterates | → Buy |
| 11/14/2019 | 654.72% | Roth Capital | → $12 | Initiates Coverage On | → Buy |
| 08/05/2019 | — | Jefferies | Downgrades | Buy → Hold | |
| 08/05/2019 | 214.47% | SunTrust Robinson Humphrey | $23 → $5 | Downgrades | Buy → Hold |
| 08/05/2019 | 277.36% | Piper Sandler | $20 → $6 | Downgrades | Overweight → Neutral |
| 04/12/2019 | — | Piper Sandler | Initiates Coverage On | → Overweight | |
| 12/18/2018 | 1409.43% | HC Wainwright & Co. | → $24 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/03/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | 購買 → 購買 |
| 06/15/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | → 購買 |
| 05/04/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | → 購買 |
| 03/30/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | → 購買 |
| 02/16/2023 | 403.14% | HC Wainwright & Co. | 13 美元 → 8 美元 | 維護 | 購買 |
| 08/04/2022 | 717.61% | HC Wainwright & Co. | 14 美元 → 13 美元 | 維護 | 購買 |
| 11/12/2021 | 151.57% | 傑富瑞 | 3 美元 → 4 美元 | 升級 | 持有 → 買入 |
| 12/08/2020 | 843.4% | 羅斯資本 | 9 美元 → 15 美元 | 維護 | 購買 |
| 2020 年 7 月 31 日 | 843.4% | HC Wainwright & Co. | 16 美元 → 15 美元 | 維護 | 購買 |
| 03/02/2020 | 906.29% | HC Wainwright & Co. | 18 美元 → 16 美元 | 重申 | → 購買 |
| 2019 年 11 月 14 日 | 654.72% | 羅斯資本 | → 12 美元 | 啓動覆蓋開啓 | → 購買 |
| 2019 年 5 月 8 日 | — | 傑富瑞 | 降級 | 買入 → 持有 | |
| 2019 年 5 月 8 日 | 214.47% | SunTrust 羅賓遜漢弗萊 | 23 美元 → 5 美元 | 降級 | 買入 → 持有 |
| 2019 年 5 月 8 日 | 277.36% | 派珀·桑德勒 | 20 美元 → 6 美元 | 降級 | 超重 → 中性 |
| 2019 年 12 月 4 日 | — | 派珀·桑德勒 | 啓動覆蓋開啓 | → 超重 | |
| 12/18/2018 | 1409.43% | HC Wainwright & Co. | → 24 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for GlycoMimetics (GLYC)?
GlycoMimetics (GLYC) 的目標價格是多少？
The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on August 3, 2023. The analyst firm set a price target for $8.00 expecting GLYC to rise to within 12 months (a possible 403.14% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月3日公佈了GlycoMimetics（納斯達克股票代碼：GLYC）的最新目標股價。這家分析公司將目標股價定爲8.00美元，預計GLYC將在12個月內上漲至403.14％（可能上漲403.14％）。去年有6家分析公司公佈了評級。
What is the most recent analyst rating for GlycoMimetics (GLYC)?
分析師對GlycoMimetics（GLYC）的最新評級是多少？
The latest analyst rating for GlycoMimetics (NASDAQ: GLYC) was provided by HC Wainwright & Co., and GlycoMimetics reiterated their buy rating.
GlycoMimetics（納斯達克股票代碼：GLYC）的最新分析師評級由HC Wainwright & Co. 提供，GlycoMimetics重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for GlycoMimetics (GLYC)?
GlycoMimetics（GLYC）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GlycoMimetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GlycoMimetics was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與GlycoMimetics的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。GlycoMimetics的最新評級是在2023年8月3日提交的，因此您應該預計下一個評級將在2024年8月3日左右公佈。
Is the Analyst Rating GlycoMimetics (GLYC) correct?
分析師對 GlycoMimetics (GLYC) 的評級正確嗎？
While ratings are subjective and will change, the latest GlycoMimetics (GLYC) rating was a reiterated with a price target of $0.00 to $8.00. The current price GlycoMimetics (GLYC) is trading at is $1.59, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的GlycoMimetics（GLYC）評級得到重申，目標股價爲0.00美元至8.00美元。GlycoMimetics（GLYC）目前的交易價格爲1.59美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。